CGRP gene-modified rBMSCs show better osteogenic differentiation capacity in vitro

Area of Science:

• Biochemistry
• Cell Biology
• Regenerative Medicine

Background:

• Calcitonin gene-related peptide (CGRP) is a neuropeptide crucial for bone repair.
• Understanding CGRP's role in osteogenic differentiation is vital for bone regeneration therapies.

Purpose of the Study:

• To investigate the effect of CGRP overexpression on the osteogenic differentiation of rat bone mesenchymal stem cells (rBMSCs).
• To elucidate the mechanism by which CGRP influences bone formation.

Main Methods:

• rBMSCs were genetically modified to overexpress CGRP using viral vectors.
• Cell proliferation was assessed using CCK-8 and flow cytometry.
• Osteogenic differentiation markers (ALP, BSP, Runx2) and mineralization were evaluated via qPCR, Western blotting, and Alizarin Red staining.
• The OPG/RANKL ratio was measured to explore the underlying mechanism.

Main Results:

• Stable CGRP overexpression in rBMSCs was successfully achieved.
• CGRP significantly promoted rBMSC proliferation and osteogenic differentiation.
• Increased expression of osteogenesis markers and enhanced mineralization nodules were observed in CGRP-overexpressing cells.
• CGRP upregulated OPG and downregulated RANKL, leading to a higher OPG/RANKL ratio.

Conclusions:

• CGRP gene modification enhances the osteogenic differentiation capacity of rBMSCs in vitro.
• CGRP plays a positive role in bone regeneration by promoting stem cell activity and modulating the OPG/RANKL pathway.